Lilly gets another obesity partner in deal with Superluminal worth up to $1.3Bnews2025-08-14T12:00:30+00:00August 14th, 2025|Endpoints News|
Sarepta sells Arrowhead stake for cash and to help fulfill milestone paymentnews2025-08-14T10:58:16+00:00August 14th, 2025|Endpoints News|
NIH backs away from mRNA research, claiming lack of public trustnews2025-08-13T19:32:31+00:00August 13th, 2025|Endpoints News|
Vedanta’s microbiome therapy fails Phase 2, company lays off 20%news2025-08-13T18:44:59+00:00August 13th, 2025|Endpoints News|
CytomX discloses patient death in study of ADC in colorectal cancernews2025-08-13T18:44:04+00:00August 13th, 2025|Endpoints News|
Endpoints 11 list 2025: Join Sept. 18 with George Church and this year’s top biotech startupsnews2025-08-13T18:19:12+00:00August 13th, 2025|Endpoints News|
Pfizer says FDA may pull its Covid vaccine for young childrennews2025-08-13T17:15:21+00:00August 13th, 2025|Endpoints News|
Compass Therapeutics sells $120M in stock; RemeGen to seek China approvalnews2025-08-13T14:46:13+00:00August 13th, 2025|Endpoints News|
Biotech industry goes six months without an IPOnews2025-08-13T14:26:54+00:00August 13th, 2025|Endpoints News|
